Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides

Clinical Rheumatology

Volumn 19, Issue 1, 2000, Pages 14-20

  Kageyama, Y ^a   Miyamoto, S ^a   Ozeki, T ^a   Hiyoshi, M ^a   Suzuki, M ^a   Nagano, A ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Matrix metalloproteinase 3; Rheumatoid factor subclasses; Synovial fluid; Tissue inhibitor of metalloproteinase 1

Indexed keywords

AUROTHIOMALATE; BUCILLAMINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ANKLE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; JOINT EFFUSION; KNEE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; SYNOVIAL FLUID;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0034048301     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050004     Document Type: Article

References (30)

1. Okada Y, Nagase H, Harris ED. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: purification and characterization. J Biol Chem 1986;261:14245-55.
2. Wu JJ, Lark MW, Chun LE, Eyre DR. Site of stromelysin cleavage in collagen types II, IX, X and XI of cartilage. J Biol Chem 1991;266:5625-8.
3. Manicourt DH, Fujimoto N, Obata K, Thonar EJMA. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinase-1 in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:1031-9.
4. Martel-Pelletier J, Pelletier JP, Cloutier JM. Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum 1984;27:305-12.
5. Murphy G, Reynold JJ, Werb Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylpholbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem 1985;260:3079-83.
6. Murphy G, Web Z. Tissue inhibitor of metalloproteinases. Identification of precursor forms synthesized by human fibroblasts in culture. Biochem Biophys Acta 1985;839:214-8.
7. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis: a longitudinal study of newly diagnosed younger adult patients. Am J Med 1979;66:377-84.
8. Van der Heijde DMFM, Riel PLCM, Rijswijk MH, Putte LBA. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 1988;17:284-92.
9. Arnason JA, Johnson Th, Brekkan A, Sigurjonsson K, Valdimarsson H. Relation between bone erosions and rheumatoid factor isotypes. Ann Rheum Dis 1987;46:380-4.
10. Teitsson I, Withrington RH, Seifert MH, Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 1984;43:673-8.
11. Pope RM, McDuffy SJ. IgG rheumatoid factor: relationship to seropositive rheumatoid arthritis and absence in seronegative disorders. Arthritis Rheum 1979;22:988-98.
12. Zlabinger GJ, Haberhauser G, Dax K, Menzel EJ, Bröll H. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis. Clin Exp Rheumatol 1990;8:113-9.
13. Arnett FC, Edworthy SM, B loch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Obata K, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for human matrix melalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
15. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases: an application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-8.
16. Brandt KD, Fife RS, Braunstein EM, Katz B. Radiographic grading of the severity of knee osteoarthritis: relation of the Kellgren and Lawrence grade to a grade based on joint space narrowing, and correlation with arthroscopic evidence of articular cartilage degeneration. Arthritis Rheum 1991;34:1381-6.
17. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and post-traumatic knee injury. Arthritis Rheum 1992;35:35-42.
18. Hayakawa T, Yamashita K, Kodama S, Iwata H, Iwata K. Tissue inhibitor of metalloproteinases and collagenase activity in synovial fluid of human rheumatoid arthritis. Biochem Res 1991;12:169-73.
19. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
20. Yoshikawa Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-75.
21. Murphy G, Koklitis P, Carne AF. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields a fully active inhibitor. Biochem J 1989;261:1031-4.
22. Weisbart RH, Noritake DT, Colburn KK. Human monoclonal IgG rheumatoid factor has structural homology with bacterial Fc receptor proteins. J Immunol 1987;139:2925-8.
23. Williams RC Jr. Hypothesis: rheumatoid factors are anti-idiotypes related to bacterial or viral Fc receptors. Arthritis Rheum 1988;31:1204-7.
24. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discordant expression of stromelysin, collagenase and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: synergistic effects of interleukin-1 and tumor necrosis factor a on stromelysin expression. J Biol Chem 1990; 265:17238-45.
25. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin-1 and tumor necrosis factor a of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1990;1052:366-78.
26. Miyasaka N, Sato K, Goto M. Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
27. Duff G. Interleukin-1 in inflammatory joint disease. In: Bomford R, Henderson B, editors. Interleukin-1: inflammation and disease. Amsterdam: Elsevier, 1989.
28. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
29. Martel PJ, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Excess of metalloproteinases over tissue inhibitor of metalloproteinase may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-15.
30. Ishiguro N, Ito T, Obata K, Fujimoto N, Iwata H. Determination of stromelysin-1 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 1996;23:1599-604.